Göran C. Sedvall

3.6k total citations · 1 hit paper
47 papers, 2.9k citations indexed

About

Göran C. Sedvall is a scholar working on Cellular and Molecular Neuroscience, Psychiatry and Mental health and Molecular Biology. According to data from OpenAlex, Göran C. Sedvall has authored 47 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Cellular and Molecular Neuroscience, 17 papers in Psychiatry and Mental health and 12 papers in Molecular Biology. Recurrent topics in Göran C. Sedvall's work include Neurotransmitter Receptor Influence on Behavior (25 papers), Schizophrenia research and treatment (16 papers) and Tryptophan and brain disorders (9 papers). Göran C. Sedvall is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (25 papers), Schizophrenia research and treatment (16 papers) and Tryptophan and brain disorders (9 papers). Göran C. Sedvall collaborates with scholars based in Sweden, United States and Germany. Göran C. Sedvall's co-authors include Erik G. Jönsson, Markus M. Nöthen, Peter Propping, Irwin J. Kopin, Lars Farde, Yoshifumi Nakashima, F Grünhage, Ingrid Agartz, Yasmin L. Hurd and Michio Suzuki and has published in prestigious journals such as American Journal of Psychiatry, The American Journal of Human Genetics and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Göran C. Sedvall

47 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers

1999 588 citations Erik G. Jönsson, Markus M. Nöthen et al. Molecular Psychiatry profile →

Peers

Göran C. Sedvall

CMN

PMH

GENET

Osamu Shirakawa Japan

Petra Franke Germany

Terry Ritchie United States

José Apud United States

Jaakko Lappalainen United States

Marco Catalano Italy

Daniela Di Bella Italy

Nicola G. Cascella United States

Nader D. Halim United States

Richard B. Rosse United States

Osamu Shirakawa Japan

Göran C. Sedvall

1.2k ×0.9

CMN

556 ×0.6

PMH

968 ×1.3

552 ×0.9

281 ×0.7

GENET

Citations per year, relative to Göran C. Sedvall Göran C. Sedvall (= 1×) peers Osamu Shirakawa

Countries citing papers authored by Göran C. Sedvall

Since Specialization

Citations

This map shows the geographic impact of Göran C. Sedvall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Göran C. Sedvall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Göran C. Sedvall more than expected).

Fields of papers citing papers by Göran C. Sedvall

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Göran C. Sedvall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Göran C. Sedvall. The network helps show where Göran C. Sedvall may publish in the future.

Co-authorship network of co-authors of Göran C. Sedvall

This figure shows the co-authorship network connecting the top 25 collaborators of Göran C. Sedvall. A scholar is included among the top collaborators of Göran C. Sedvall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Göran C. Sedvall. Göran C. Sedvall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Söderman, Erik, et al.. (2018). No major influence of regular tobacco smoking on cerebrospinal fluid monoamine metabolite concentrations in patients with psychotic disorder and healthy individuals. Psychiatry Research. 263. 30–34. 1 indexed citations

Andreou, Dimitrios, Erik Söderman, Tomas Axelsson, et al.. (2015). Cerebrospinal fluid monoamine metabolite concentrations as intermediate phenotypes between glutamate-related genes and psychosis. Psychiatry Research. 229(1-2). 497–504. 9 indexed citations

Andreou, Dimitrios, Erik Söderman, Tomas Axelsson, et al.. (2014). Polymorphisms in genes implicated in dopamine, serotonin and noradrenalin metabolism suggest association with cerebrospinal fluid monoamine metabolite concentrations in psychosis. Behavioral and Brain Functions. 10(1). 26–26. 35 indexed citations

Andreou, Dimitrios, Peter Saetre, Thomas Werge, et al.. (2012). d-amino acid oxidase activator gene (DAOA) variation affects cerebrospinal fluid homovanillic acid concentrations in healthy Caucasians. European Archives of Psychiatry and Clinical Neuroscience. 262(7). 549–556. 10 indexed citations

Annerbrink, Kristina, Erik G. Jönsson, Marie Olsson, et al.. (2010). Associations between the angiotensin-converting enzyme insertion/deletion polymorphism and monoamine metabolite concentrations in cerebrospinal fluid. Psychiatry Research. 179(2). 231–234. 17 indexed citations

Vares, María, et al.. (2006). Characterization of Patients with Schizophrenia and Related Psychoses: Evaluation of Different Diagnostic Procedures. Psychopathology. 39(6). 286–295. 50 indexed citations

Sedvall, Göran C., Erik G. Jönsson, Gaku Okugawa, et al.. (2005). Altered White Matter/Gray Matter Proportions in the Striatum of Patients With Schizophrenia: A Volumetric MRI Study. American Journal of Psychiatry. 162(12). 2315–2321. 45 indexed citations

Jönsson, Erik G., Anna Sillén, María Vares, et al.. (2003). Dopamine D2 receptor gene Ser311Cys variant and schizophrenia: association study and meta‐analysis. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 119B(1). 28–34. 52 indexed citations

Bogaert, Ann Van Den, Johannes Schumacher, Thomas G. Schulze, et al.. (2003). The DTNBP1 (Dysbindin) Gene Contributes to Schizophrenia, Depending on Family History of the Disease. The American Journal of Human Genetics. 73(6). 1438–1443. 159 indexed citations

10.

Carmine, Andrea, Milan G. Chheda, Erik G. Jönsson, et al.. (2003). Two NOTCH4 polymorphisms and their relation to schizophrenia susceptibility and different personality traits. Psychiatric Genetics. 13(1). 23–28. 15 indexed citations

11.

Jönsson, Erik G., Nadine Norton, Kaj Forslund, et al.. (2003). Association between a promoter variant in the monoamine oxidase A gene and schizophrenia. Schizophrenia Research. 61(1). 31–37. 43 indexed citations

12.

Buervenich, Silvia, Fengqing Xiang, Olof Sydow, et al.. (2001). Identification of four novel polymorphisms in the calcitonin/α-CGRP (CALCA) gene and an investigation of their possible associations with Parkinson disease, schizophrenia, and manic depression. Human Mutation. 17(5). 435–436. 19 indexed citations

13.

Hurd, Yasmin L., Michio Suzuki, & Göran C. Sedvall. (2001). D1 and D2 dopamine receptor mRNA expression in whole hemisphere sections of the human brain. Journal of Chemical Neuroanatomy. 22(1-2). 127–137. 199 indexed citations

14.

Jönsson, Erik G., Markus M. Nöthen, F Grünhage, et al.. (1999). Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers. Molecular Psychiatry. 4(3). 290–296. 588 indexed citations breakdown →

15.

Jönsson, Erik G., Feng Zhang, Vishwajit L. Nimgaonkar, William A. Rudert, & Göran C. Sedvall. (1998). Lack of association between schizophrenia and HLA DQB1 alleles in a Swedish sample. Schizophrenia Research. 29(3). 293–296. 14 indexed citations

16.

Jönsson, Erik G., et al.. (1998). Lack of association between debrisoquine 4-hydroxylase (CYP2D6) gene polymorphisms and schizophrenia. Psychiatric Genetics. 8(1). 25–28. 14 indexed citations

17.

Jönsson, Erik G., David Goldman, Gillian Spurlock, et al.. (1997). Tryptophan hydroxylase and catechol-O-methyltransferase gene polymorphisms: relationships to monoamine metabolite concentrations in CSF of healthy volunteers. European Archives of Psychiatry and Clinical Neuroscience. 247(6). 297–302. 99 indexed citations

18.

Jönsson, Erik G., C. Härnryd, Jan Wahlström, et al.. (1997). Further studies on a male monozygotic triplet with schizophrenia: cytogenetical and neurobiological assessments in the patients and their parents. European Archives of Psychiatry and Clinical Neuroscience. 247(5). 239–247. 3 indexed citations

19.

Sedvall, Göran C.. (1996). Neurobiological correlates of acute neuroleptic treatment. International Clinical Psychopharmacology. 11(Supplement 2). 41–46. 18 indexed citations

20.

Sedvall, Göran C., Virginia K. Weise, & Irwin J. Kopin. (1968). THE RATE OF NOREPINEPHRINE SYNTHESIS MEASURED IN VIVO DURING SHORT INTERVALS; INFLUENCE OF ADRENERGIC NERVE IMPULSE ACTIVITY. Journal of Pharmacology and Experimental Therapeutics. 159(2). 274–282. 145 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact